Proximal femoral bionic nail (PFBN) offers comparable functional and clinical outcomes to PFNA and intertan in the treatment of intertrochanteric fractures: a systematic review and meta-analysis

近端股骨仿生钉(PFBN)在治疗股骨粗隆间骨折方面,与PFNA和intertan相比,可提供相当的功能和临床疗效:系统评价和荟萃分析

阅读:2

Abstract

BACKGROUND: Intertrochanteric fractures represent nearly 45% of hip fractures and are rising due to global aging. Surgical fixation, especially intramedullary nailing with PFNA or InterTAN, is the preferred treatment. However, complications like implant failure persist. The proximal femoral bionic nail (PFBN), designed to mimic natural femoral anatomy, has emerged as a promising alternative. This systematic review and meta-analysis aimed to compare PFBN with PFNA or InterTAN. METHODS: This study followed PRISMA guidelines and was registered on PROSPERO. A comprehensive search of PubMed, Scopus, Web of Science, Embase, Cochrane Library, and Google Scholar was conducted up to June 2025. Studies comparing PFBN with PFNA or InterTAN and reported clinical outcomes were eligible. Two authors independently conducted study selection, data extraction, and risk of bias assessment using ROBINS-I. Also, random-effects meta-analysis, publication bias, sensitivity analysis, and GRADE assessment were conducted. RESULTS: A total of 11 retrospective cohort studies were included. PFBN showed significantly shorter fracture healing and time to weight-bearing compared to both PFNA and InterTAN. The PFBN had a significantly longer surgery duration than the PFNA. No significant differences were found in intraoperative blood loss, hospital stay, Harris Hip Score, or complication rates between PFBN and other devices. Most studies had a low to moderate risk of bias. GRADE assessments mainly indicated moderate to high certainty of evidence. CONCLUSION: This study indicated PFBN as a promising alternative for intertrochanteric fractures, offering faster fracture healing and earlier weight bearing, with similar blood loss, complications, and functional outcomes to PFNA and InterTAN .

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。